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SufentanilAbstract Background: Labor sufentanil impact on the newborn is debatable. This randomized
double-blind investigation examined the transplacental conveyance and neonatal inﬂuences of son-
ophoretic versus epidural sufentanil for labor analgesia and its outcome on breast-feeding.
Methods: 60 Healthy parturient women receiving labor epidural analgesia were enrolled in the
study. They were administered epidural bupivacaine (12-ml bolus then 10 ml/h of 0.125%) solely
(Group I, n= 20) or with sonophoretically transdermally administered sufentanil (Group II,
n= 20) or with epidurally administered sufentanil (Group III, n= 20). Sufentanil received by
Groups II and III was 15 lm followed by 10 ml/h of 0.25 lm/ml solution.
Results: Sufentanil was detected in ﬁve umbilical arterial (UA) samples in Group III versus in two
UA samples in Group II. Neonatal Neurologic and Adaptive Capacity Score (NACS) at 24 h was
lowest in Group III (P= 0.04). On postpartum day 1, Group III women reported breast-feeding
388 R.H. Saleh et al.difﬁcultly (25%) more oftentimes than Group II women (10%), or Group I women (5%)
(P= 0.05). There was 45% breast-feeding difﬁculty in each group according to lactation
consultant’s assessment (P= 1.0). At 6 weeks postpartum, more Group III women were not
breast-feeding (35%) than Group II women (10%) or Group I (10%) (P= 0.004).
Conclusion: Sufentanil transplacental transport and fetal exposure appeared greater in epidural
than in sonophoretic sufentanil. The former group women were facing more difﬁculty at starting
breast-feeding on postpartum day 1 and were more apt to have stopped breast-feeding 6 weeks post-
partum than the latter group women.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license.1. Introduction
Different clinical practices were associated with breast-feeding
problems. Nevertheless, minimal is acknowledged around the
validity of obstetrical pain management procedures and anal-
gesia effects on breast-feeding conduct [1].
The issue of ‘‘not having sufﬁcient milk’’ was much more
addressed by those women who had epidural analgesia. Addi-
tional studies conducted prospectively are required to institute
whether a causal relation exists between epidural analgesia and
breast-feeding problems [1].
Disputation exists regarding the outcome of opioid-supple-
mented parturition epidural analgesia on neonatal well-being
after delivery. Initial investigations in this ﬁeld were centered
on the consequence of epidural analgesia on the neonate’s
neuro-behavior, and they yielded inconsistent results [2,3].
The clinical signiﬁcance of altered neurobehavioral scores is
controversial [4], but observational grounds suggest an inﬂu-
ence on the newborn’s power to breast-feed [5]. Breast milk
is regarded the optimal nutrition for neonates [6].
Sonophoresis refers to the use of ultrasound for the
transdermal delivery of drugs. It was shown to increase the skin
permeability to a wide range of therapeutic agents including
hydrophilic molecules, macromolecules [7] and various low
and high molecular weight medications including heparin and
insulin [8]. Especially low-frequency sonophoresis (LFS) which
utilizes low-frequency ultrasound [7]. This novel technology
offers promising potential for noninvasive and non-painful
drug administration. Sonophoretic cavitation was proposed
to be the mechanism through which low-frequency ultrasound
delivers drugs transdermally, effectively [9] and safely through
the stratum corneum which is the natural barrier which limits
substances penetration through the skin with future trends even
in the ﬁeld of gene delivery and cutaneous vaccination [10].
Neonatal issues (e.g., newborn does not lock properly onto
the breast or suckle considerably, palate anomalies) and moth-
erly issues (e.g. nipples problems, deﬁcient training) can impact
breast-feeding. Regional anesthesia has become progressively
favorable for child birth analgesia. Nevertheless, its impact
on breast-feeding has been questioned [5].
The worry concerning epidural analgesia and breast-feeding
is that epidural pharmaceutics, especially opioids, traverses the
placental barrier impairing neuro-behavior scores, which ulti-
mately may possess an outcome on breast-feeding. This fear
has not been veriﬁed as only few studies speciﬁcally investi-
gated whether epidural analgesia affects breast-feeding [3].
This controlled, randomized, double-blind research work
was intended to examine the transplacental transport of son-
ophoretically administered transdermal sufentanil as com-pared to epidural sufentanil in childbirth peridural analgesia
and to ascertain if they do inﬂuence breast-feeding.
2. Materials and methods
The work protocol was authorized by Cairo University
Hospital ethical committee. 60 Healthy multiparous parturi-
ent women who presented for an attempted vaginal delivery
at term, who previously breast-fed a kid for at minimal
6 weeks and intended to breast-feed this child were ran-
domly double-blinded included in this study. After accept-
ing or requesting epidural analgesia, the patient was
randomly appointed to one of three cardinal groups
according to a computer-generated randomization block
using sealed opaque envelopes opened immediately before
placement of the epidural.
The studied patients were administered epidural bupiva-
caine solely (Group I, n= 20) or with sonophoretic transder-
mal sufentanil (Group II, n= 20) or with epidural sufentanil
(Group III, n= 20).
The study transdermal solution was applied, using an oil
sprayer, to a rectangular area of 15 cm · 7 cm on the front
aspect of the left thigh of the studied patients in a circular reg-
ular clockwise motion at average speed of 1 cm/s using the por-
table ultrasonic probe of lipo X machine (LP 200, South
Korea) (Fig. 1) emitting low frequency (30KHz) ultrasonic
cavitational waves adjusted at its highest intensity while apply-
ing ﬁrm pressure over the skin after being sterilized with ster-
illium (Bode Chemie, Hamburg). Skin area chosen must be of
healthy intact unshaved skin with no signs of hyperkeratosis.
This circular motion was maintained with average circular cir-
cumference of 10 cm till all of the study solution was absorbed.
Written acknowledged consent was obtained before the
start of aching unpleasant contractions. If the parturient was
administered any intravenous analgesics during birth e.g.
meperidine or other narcotics, she was not entitled in this
research work.
If the parturient underwent cesarean section, she was also
excluded from the contemplate.
The neonatologist, trained to perform the Neurologic and
Adaptive Capacity Scoring System (NACS), assessed the
infant by the blinded pediatrician. The NACS is an assessment
of alertness, response to light and sound and passive and active
tone reﬂexes. Its evaluated score is between 0 and 40.
The use and dose of any postoperative drugs administered
in the postpartum period were reported from the patient’s
medical records. Also, whether or not supplemental bottle
feeding was received by the infant was ascertained by review-
ing the infant’s medical record.
Figure 1 Liop X machine.
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lactation and reported a 12-point B-R-E-A-S-T Feeding Obser-
vationForm [11]. This forms apart of a breast-feeding education
course sponsored by the World Health Organization and the
United Nations Children’s Fund. The breast-feeding consul-
tant, in addition to identifying any breast-feeding problems,
gave a judgment concerning whether the child was having difﬁ-
cultness with lactation (none, mild, moderate, or severe).
The (yes or no questionnaire) (Table 1) and the B-R-E-A-S-
T Feeding Observation Form (Table 2) were previously used in
similar relevant studies. All mothers were called by one mem-
ber of the research team at 6 weeks postpartum to ﬁnd out
whether they were still lactating.Table 1 Breast-feeding conditions of the infants as judged by the m
No sufentanil
group (n= 20)
Sono
sufe
Infant drops asleep 11 12
Infant spits 10 18
Infant unhappy after feeding 10 5
Infant feeds from one breast 7 4
Infant feeds frequently 7 5
Infant refuses to nurse 13 15
Infant’s sucking is not eﬀective 3 7
Infant fails to latch on the nipple 15 17
Infant nursing time is long 15 7If the mother was not lactating at 6 weeks postpartum, she
was asked as to whether this was associated with difﬁcultness
the infant experienced with breast-feeding.
3. Statistical analysis
Pilot observational study results revealed the basic design pro-
tocol for the current study determining deﬁnition of the study
groups and the sample size. What medications, if any, were
given during childbirth was determined by reviewing the med-
ical records. Much difﬁcultness in assessing effect of anesthet-
ics was met in the pilot study with ﬁrstborns. Thus, the current
study was limited to those who breastfed previously.
Different routes of sufentanil administration were applied
among patients in the pilot study. Thus, in the present study
patients were designed to receive either no labor sufentanil,
sonophoretic transdermal sufentanil or epidural sufentanil.
Power analysis revealed that a sample size of 60 would be
enough to render 80% power to detect a difference between
the no sufentanil group, sonophoretic transdermal sufentanil
group and epidural sufentanil group. These values render an
overall signiﬁcance level of 0.05, based on two pairwise two-
tailed tests. Kruskal–Wallis tests were used to compare contin-
uous variables among groups while chi-square tests were used
to compare binary outcomes.
4. Results
60 Women were entitled in this clinical research, successfully
completed the study protocol and their results analyzed.
Childbirth and Demographic data were comparable among
groups, as were the period of labor analgesia and type of
delivery. More than 90% had a normal spontaneous vaginal
delivery and the rest were forceps-assisted vaginal deliveries
(Table 3).
No signiﬁcant difference was attainable in Apgar score
among the three cardinal groups at 1 or 5 min (median score
of 9 in all three groups at 1 and 5 min). Moreover, no signiﬁ-
cant difference among the studied groups was met regarding
the number of infants who received supplemental bottle feed-
ing (Table 4).
Signiﬁcant differences were found among the three studied
groups concerning the total amount of bupivacaine received
but not among groups II and III concerning the total amount
of sufentanil received. On the other hand, sufentanil concentra-
tions in the umbilical cord differed among groups but bupiva-
caine cord concentrations did not. This is shown in Table 4.other.
phoretic transdermal
ntanil group (n= 20)
Epidural sufentanil
group (n= 20)
P value
18 0.21
17 0.09
16 0.29
10 0.71
5 0.69
16 0.06
12 0.09
17 0.35
14 0.79
Table 2 Breast-feeding conditions as judged by the lactation consultant.
No sufentanil
group (n= 20)
Sonophoretic transdermal
sufentanil group (n= 20)
Epidural sufentanil
group (n= 20)
P value
Infant is not responding to breast 5 12 12 0.17
Infant cannot hold the breast 8 14 10 0.47
Infant is not rooting 3 9 12 0.17
Infant’s mouth is closed 6 16 8 0.48
Infant’s lower lip turned in 8 13 11 0.41
Infant’s tongue is not visible 6 12 9 0.69
Cheeks are pulled in 3 4 4 1.12
Infant sucks rapidly 8 17 8 0.89
Infant smacks 4 11 6 0.71
Infant fails to latch on 2 7 9 0.13
Infant drops asleep 160 18 17 0.91
Infant sucking is poor 10 12 13 0.88
Table 3 Patients demographic data and childbirth characteristics.a
No sufentanil
group (n= 20)
Sonophoretic transdermal
sufentanil group (n= 20)
Epidural sufentanil
group (n= 20)
Age in years 32 (24–40) 34 (20–39) 31 (23–43)
Height in cm 160 (151–170) 158 (148–169) 157 (147–171)
Weight in kg 84 (68–106) 81 (66–98) 83 (65–112)
Duration of peridural analgesia, min 288 (33–776) 304 (40–787) 279 (35–775)
Oxytocin used, number of patients 18 16 17
Highest oxytocin dose, mU 7 (3–19) 6 (2–21) 7 (3–19)
NSVD, number of patients 17 19 19
Parity 3 (3–5) 3 (1–7) 2 (2–3)
a Demographic data of the patients according to their groups are presented as median and range or number of patients. NSVD= normal
spontaneous vaginal delivery (the rest were assisted deliveries by forceps).
Table 4 Apgar scores, drug concentrations, NACS and breast feeding.a
No sufentanil
group (n= 20)
Sonophoretic transdermal
sufentanil group (n= 20)
Epidural sufentanil
group (n= 20)
P value
Apgar score at 1 min 9 (7–10) 9 (8–9) 9 (8–10) 0.53
Apgar score at 5 min 9 (8–9) 9 (8–9) 9 (8–10) 0.62
External bottle feeding 68% 73% 76% 0.62
Total sufentanil in labor, lg Nil 18 (3–45) 22 (6–40) 0.00010
Sufentanil in cord, pg/ml Nil 5 (0–12) 12 (0–25) 0.00010
Total bupivacaine in labor, mg 78.5 (40–178) 50.4 (26.5–283.7) 48 (19–76) 0.00010
Bupivacaine in cord, ng/ml 12.1 (0.2–63.5) 9.2 (0.1–53.6) 8.9 (0.1–52.7) 0.54
NACS score at 24 h 34 (23–40) 32 (18–40) 31 (19–40) 0.04
BF diﬃculty at 24 h postpartum by mother 1 (5%) 2 (10%) 5 (25%) 0.05
BF diﬃculty at 24 h postpartum by BF consultant 9 (45%) 9 (45%) 9 (45%) 1.2
Failed BF at 6 weeks 2 (10%) 2 (10%) 7 (35%) 0.0040
a Data are recorded according to the patient’s group assignment and are presented as median and range or percent. BF = breast-feeding;
NACS= neurologic and adaptive capacity scoring system. BF = breast feeding. 0P value < 0.005 statistical signiﬁcance.
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transdermal sufentanil group was 18 (3–45) lm and in
epidural sufentanil group was 22 (6–40) lm. Though sufentanil
was administered in the epidural and sonophoretic transdermal
groups in comparable doses, sufentanil epidural and
sonophoretic transdermal groups MV plasma concentrations
of sufentanil were in the ratio of 6:1. UV/MV sufentanil ratios
were 0.45 in sonophoretic transdermal sufentanil group and
0.83 in epidural sufentanil group. Sufentanil was detected in ﬁve
UA samples i.e. in 5 neonates in epidural sufentanil group,
whereas it was detected in exclusively two samples in sonopho-
retic transdermal sufentanil group.Breast feeding problems reported at 24 h after delivery in
the maternal overall assessment were in 8 patients (13%). 3
of these were mild problems, 4 were moderate and one was
severe.
On postpartum day 1, women who were randomly
appointed to acquire epidural sufentanil reported breast-feed-
ing difﬁcultly (25%) more oftentimes than women who were
randomly appointed to acquire sonophoretic transdermal
sufentanil (10%), or no sufentanil (5%) and this achieved sta-
tistical signiﬁcance (P= 0.05).
Most of the issues reported were related to the infant being
sleepy (45%), the infant being unable to latch on the nipple
Transplacental transfer and neonatal inﬂuences of sonophoretically administered sufentanil 391(20%) and the infant being fuzzy refusing to feed (16%). This
is revealed in Table 1.
On the other hand, there was also no signiﬁcant disagree-
ment among groups in breast-feeding difﬁculty according to
the lactation consultant’s assessment (45% difﬁculty in each
group; P= 1.0).
In the breastfeeding consultant’s evaluation at 24 h after
childbirth 27 of 60 infants (45%) were identiﬁed as having
breast-feeding difﬁcultness. The magnitude was comparable in
all groups. Of the 27 cases, 15 were categorized as mild (56%),
10 were categorized as moderate (37%), and 2 were categorized
as severe (7%). One severe breast-feeding difﬁculty occurred in
the epidural sufentanil group (Group III), and two problems
occurred in the sonophoretic transdermal sufentanil group
(Group II). The problems most frequently encountered were
the infant being sleepy (29%) and the lip being turning in
(16%), without statistical variation between the groups (Table 2).
Much more mothers who were administered epidural sufen-
tanil reported difﬁcultness (25%) than those whom were
administered sonophoretic transdermal sufentanil (10%) or
no sufentanil (5%) (P= 0.05).
At 6 weeks postpartum, there were 11 women (18%) who
were not breast-feeding. More women who were randomly
appointed to acquire epidural sufentanil were not breast-feed-
ing (35%) than women who were randomly appointed to
acquire either sonophoretic transdermal sufentanil (10%) or
no sufentanil (10%) (P= 0.004). The small number of patients
must be borne in mind.
In all situations, stopping breastfeeding was reported by the
mother to be due to the infant having breastfeeding difﬁculties.
Generally, when a patient reported a difﬁculty at 24 h, she was
more prone not to be breast-feeding at 6 weeks (29%) than if
she did not report a difﬁculty at 24 h (10%) (P= 0.005).
Newborn status was favorable and mostly comparable in
all groups at all timings, with the exclusion of a lowest NACS
at 24 h in Group III receiving the epidural sufentanil
(P= 0.04). The infant’s NACS median scores encountered
at 24 h were 34, 32, and 31 in the no sufentanil, sonophoretic
transdermal sufentanil and epidural sufentanil groups, respec-
tively. The 24-h and 6 weeks postdelivery differences were also
statistically identiﬁed among studied patients when assessed in
relation to the total amount of sufentanil received epidurally.
Positive correlation was found between the maternal
assessment of problematic breast-feeding at 24 h and NACS
score (P= 0.0005), but this association was not found
between NACS score and the breastfeeding consultant’s
assessment of difﬁcultness in breast-feeding (P= 0.55) or
between NACS score and breast-feeding failure at 6 weeks
(P= 0.57). No positive relationship was revealed between
lactation success at 6 weeks and the breast-feeding consul-
tant’s evaluation at 24 h or with the NACS. In addition, nei-
ther the duration of labor nor the period when the initial
dose of sufentanil was administered until delivery did bear
any relationship to the occurrence of breast-feeding prob-
lems at 24 h or 6 weeks postpartum.5. Discussion
In this study 60 healthy parturient women receiving labor epi-
dural analgesia were enrolled. They were administered epidu-
ral bupivacaine (12-ml bolus then 10 ml/h of 0.125%) solely(Group I, n= 20) or with sonophoretically transdermally
administered sufentanil (Group II, n= 20) or with epidurally
administered sufentanil (Group III, n= 20). Sufentanil was
detected in 5 umbilical arterial (UA) samples in Group III ver-
sus in 2 UA samples in Group II.
Neonatal Neurologic and Adaptive Capacity Score
(NACS) at 24 h was lowest in Group III (P= 0.04).
On postpartum day 1, Group III women reported breast-
feeding difﬁcultly (25%) more oftentimes than Group II
women (10%), or Group I women (5%) (P= 0.05). There
was 45% breast-feeding difﬁculty in each group according
to lactation consultant’s assessment (P= 1.0).
At 6 weeks postpartum, more Group III women were not
breast-feeding (35%) than Group II women (10%) or Group
I (10%) (P= 0.004).
Several studies investigated the relation between peridural
analgesia and breastfeeding, as breast milk is considered the
ﬁrst and best newborn nutrition [2,6].
The use of transdermal route for drug delivery by sonopho-
resis is a promising technique [7].
The principal revelation of the present contemplate was
regarding previously successfully breast-feeding mothers receiv-
ing epidural analgesia in vaginal deliveries. Those who received
epidural sufentanil were more difﬁcult in starting breast feeding
on post-partum day one and were least probably breast-feeding
6 weeks postpartum as compared with women who acquired
sonophoretic transdermal sufentanil or no sufentanil.
Recent studies discovered that sonophoresis is an effective
technique in delivering proteins, hormones, vaccines, and other
nanoparticles. Moreover, It is already clinically widely used for
topical anesthetics [7].
It was also proved that low frequency ultrasound
(LFS) increases trandermal transport of several drugs
up to 1000 times even higher than therapeutic ultrasound [12].
Ueda et al. in 2009, revealed that the cavitation properties
of low frequency ultrasound is the enhancing mechanism of
LFS for transdermal drug delivery [13].
Moreover, Tezel et al. revealed successful transdermal
delivery of anti-sense oligonucleotides by the use of low-fre-
quency ultrasound [14].
It was previously been revealed that those who acquired
peridural and intravenous analgesia during childbirth did not
breast-feed as considerably during the initial post delivery per-
iod but with no alteration on breast-feeding capability at
6 weeks post delivery as evaluated by breastfeeding consultants
through phone conversations [15].
The easiness and non-invasive nature of LFS makes its use
more save when compared with an invasive route for analgesia
such as the epidural route.
Using LFS as a route of drug delivery through the skin in
addition to its safety and easiness, it avoids ﬁrst pass gut
and hepatic metabolism, maintains constant drug levels in
bloodstream for longer times and decreases potential side
effects [8,16].
Ultrasound sonophoresis for analgesic drugs delivery was
also used in the treatment of carpal tunnel syndrome, teeth
extraction, and topical analgesia [17].
LFS increases skin accumulation of Cyclosporine A helping
the targeting of the drug without a concomitant increase in its
side effects [18].
Halpern et al. performed phone conversations at 6–8 weeks
postpartum to check whether women were consistently lactat-
392 R.H. Saleh et al.ing. They found no relation between delivery analgesia and
lactation problems [19].
Similar tools were used for evaluation of success of lactation
in the current study. Individual variables as well as the woman
and breastfeeding consultant judgment regarding if the newborn
was experiencing lactation problems were both assessed.
Baumgarder et al. studiedbreastfeeding in the ﬁrst 24 h in 231
mothers if they managed to deliver a minimum of two lactation
sessions. They administered peridural analgesia 115 mothers
and compared themwith the other 116 control womenwhowere
not given peridural analgesia. It was revealed in mothers who
with peridural analgesia lactation sessions were fewer by
(70%) than the mothers with no peridural analgesia (90%).
Epidural analgesia with narcotics carries the risk of
increased complications such as nausea, vomiting, itching,
hypotension and urinary retention.
Nevertheless, the studywas not randomized and therewas not
any statement of the drugs used epidurally.Moreover, no evalua-
tions were done anywhere later than twenty-four hours [20].
It was obvious that the women who suffered problems at
the ﬁrst day postpartum were more prone to stop lactation
at 6 weeks, which is well more than the period required by
the infant and the mother to develop lactation skills and breast
milk amount is considerably enough [21].
There is no single optimal drug or mixture of drugs for
childbirth peridural analgesia. The tendency among anesthe-
tists is using minute concentrations of regional anesthetics dur-
ing childbirth peridural analgesia to prevent lower body motor
blockade. This is mostly established by adding opioids like fen-
tanyl or sufentanil via different delivery routes [22].
This contemplate did not study the relation between epidu-
rals and breast-feeding, but exclusively the interferences of var-
ious delivery routes of sufentanil among women who acquire
an epidural. The frequency of lactation problems was consid-
erable among groups at 24 h and at 6 weeks post delivery.
According to the results of the present contemplate, it is
advised to have a consensus regarding the safe use of labor
sufentanil and to build up more consciousness on the potenti-
ality of lactation problems that can be related to its use and
that may be well minimized using alternate novel routes of
drug administration and solved by early management and
training.
To conclude, it was revealed that multiparous mothers,
who previously breast-fed and acquired epidural sufentanil
had a signiﬁcantly inferior lactation success rate at 24 h and
at 6 weeks postpartum as compared with the corresponding
mothers who acquired sonophoretic transdermal sufentanil
or no sufentanil.
Therefore, this does not entail any recommendation con-
cerning abandoning using labor sufentanil as this may arise
other complications as increasing instrumental deliveries.
Sonophoretically administered sufentanil is an effective
non-invasive route for pain relieve during normal vaginal
delivery with comparable analgesic results to that of epidural
sufentanil with less adverse effects. Further studies need to
be performed on larger number of patients and on other
modalities of painful conditions.
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